Use of OPAL-COVID, a mobile application, for real-time at home follow-up of people who test positive for COVID-19 at the Glen site: a feasibility study [Funder: MI4]
- Funded by Other Funders (Canada)
- Total publications:0 publications
Grant number: unknown
Grant search
Key facts
Disease
COVID-19Start & end year
N/AFunder
Other Funders (Canada)Principal Investigator
Lebouche, BertrandResearch Location
CanadaLead Research Institution
McGill UniversityResearch Priority Alignment
N/A
Research Category
Clinical characterisation and managementResearch Subcategory
Supportive care, processes of care and managementSpecial Interest Tags
Digital Health, InnovationStudy Type
ClinicalClinical Trial Details
UnspecifiedBroad Policy Alignment
PendingAge Group
UnspecifiedVulnerable Population
UnspecifiedOccupations of Interest
Unspecified
Abstract
A mobile app can monitor COVID-19 patients. A primary aim of public health agencies is to identify, monitor, track, isolate, and treat anyone with symptoms of COVID-19 to prevent transmission. Around 90% of those who test positive for COVID-19 stay home after diagnosis. Infectious disease primary care specialist Dr. Bertrand Lebouché is teaming up with Opal app creators Dr. John Kildea and Dr. Tarek Hijal to create an app that provides resources for COVID-19 patients isolating at home. Patients will be able to self-monitor symptoms and connect with health care providers if their illness worsens. This innovation will improve safety for those isolating at home with COVID-19 and provide critical data on COVID-19 illness to help us better understand the disease.